Pharmacogenetic drug use in young danish individuals with severe mental disorders
Introduction Pharmacogenetics (PGx) studies genetic variance and related differences in drug outcomes. PGx guidelines for psychotropic drugs are available (PGx drugs), but PGx testing is used only limitedly in psychiatric clinical practice. Objectives The aim of this study is to pinpoint differe...
Main Authors: | C. Lunenburg, K. Ishtiak-Ahmed, T. Werge, C. Gasse |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2021-04-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933821003941/type/journal_article |
Similar Items
-
Pharmacogenetic profiles of young danish individuals with and without severe mental disorders
by: C. Lunenburg, et al.
Published: (2021-04-01) -
Pharmacogenetics and adhd treatment outcomes in the danish population-based IPSYCH sample
by: C. Lunenburg, et al.
Published: (2021-04-01) -
Clinical Impact of Functional CYP2C19 and CYP2D6 Gene Variants on Treatment with Antidepressants in Young People with Depression: A Danish Cohort Study
by: Liv S. Thiele, et al.
Published: (2022-07-01) -
Pharmacogenetics and antidepressant treatment outcomes in pregnancy: a Danish-population based study
by: M. Mushtaq, et al.
Published: (2022-06-01) -
Clinical impact of functional CYP2C19 and CYP2D6 gene variants on treatment outcomes in patients with depression: a Danish cohort study
by: L. Thiele, et al.
Published: (2022-06-01)